Clinical trials
Mental Disorders trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 9 |
| Unknown status | 9 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Mental Health Center | 7 |
| AstraZeneca | 2 |
| Fujian Provincial Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Wuhan University | 2 |
| Beijing HuiLongGuan Hospital | 1 |
| Central South University | 1 |
| ChunBao Li | 1 |
| Cui Yimin | 1 |
| Deng Dongrui | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mental Disorders | 38 |
| Alzheimer Disease | 6 |
| Nervous System Diseases | 6 |
| Neurodegenerative Diseases | 6 |
| Bipolar Disorder | 5 |
| Brain Diseases | 5 |
| Central Nervous System Diseases | 5 |
| Dementia | 5 |
| Schizophrenia | 5 |
| Cognitive Dysfunction | 4 |
Trials
Showing 76 to 38 of 38. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.